Enjoy complimentary customisation on priority with our Enterprise License!
The infectious disease diagnostics market market size is forecast to increase by USD 8.90 billion, at a CAGR of 4.5% between 2023 and 2028. The growth of the market hinges on several pivotal factors. Firstly, the increasing prevalence of infectious diseases worldwide is driving demand for rapid diagnostic solutions and Point-of-Care (POC) testing. These advancements enable quicker and more accurate diagnoses, crucial for timely treatment and containment of diseases. Secondly, the continuous development of novel drugs and therapies addresses emerging health challenges and enhances treatment efficacy. Thirdly, the rising adoption of POC testing devices by healthcare providers and laboratories streamlines diagnostic processes, reduces turnaround times, and improves patient outcomes. Together, these factors contribute to the dynamic expansion of the diagnostic and pharmaceutical sectors, supporting healthcare systems globally in managing and combating infectious diseases effectively.
For More Highlights About this Report, Request Free Sample
Infectious diseases continue to pose a significant global health threat, necessitating prompt and accurate diagnosis. Medical testing plays a crucial role in identifying the causative organism and initiating appropriate treatment. The market for infectious disease diagnostics is driven by the high disease prevalence of tuberculosis, HIV or AIDS, hepatitis, sexually transmitted infections, and respiratory infections. Clinical laboratories, urgent care centers, emergency rooms, ambulances, and physicians rely on skilled technicians and advanced instruments to provide rapid results. Urine, mucus, and body fluids are common samples used for diagnosis. Infection control and personal health are essential considerations in this field, emphasizing the importance of hygiene and cleanliness. The market is expected to grow due to increasing medical tourism and the need for prompt diagnosis in various healthcare settings. Laboratory tests are an integral part of disease management, enabling effective treatment and improving patient outcomes.
The increasing prevalence of infectious diseases is notably driving market growth. Infectious diseases pose a significant health threat worldwide, with organisms such as bacteria, viruses, fungi, and parasites being the causative agents. The rise in infectious diseases can be attributed to various factors, including poor water sanitation, inadequate hygiene facilities, and changing lifestyles that weaken immunity. According to the World Health Organization (WHO), infectious diseases accounted for approximately 15 million deaths in 2016. HIV/AIDS remains a leading cause of death, with UNAIDS reporting 680,000 deaths from AIDS-related illnesses in 2020. Prompt diagnosis is crucial in infection control, particularly in healthcare settings such as hospitals. Chest X-rays, CT scans, physical exams, and laboratory tests, including PCR testing, are commonly used for diagnosing infectious diseases. Skilled technicians and physicians analyze samples of respiratory secretions, blood, urine, mucus, and other body fluids to identify the causative organism.
Further, instruments used for diagnosis include microscopes, culture media, and molecular testing equipment. Private and government organizations invest in research and development to improve diagnostic tools and techniques. For instance, RNA viruses like Hepatitis C and respiratory diseases such as pneumococcal pneumonia are being addressed through advanced diagnostic methods. The geriatric population is particularly vulnerable to infectious diseases due to weakened immune systems. Therefore, effective diagnostic tools are essential to prevent infections and save lives. Thus, such factors are driving the growth of the market during the forecast period.
Increase in mergers and acquisitions is the key trend in the market. The market is experiencing significant growth due to the increasing importance of prompt diagnosis in controlling the spread of infectious diseases. Infectious diseases, including bacteria, viruses, fungi, parasites, and RNA viruses such as Hepatitis C, pose a major health concern, particularly in settings with poor water sanitation and inadequate hygiene facilities. Hospitals, healthcare professionals, and private and government organizations are investing in advanced diagnostic tools to identify the causative organism in a timely manner. Respiratory diseases, such as pneumonia, are major applications of infectious disease diagnostics. Chest X-rays, CT scans, physical exams, and laboratory tests, including PCR testing, are commonly used for the diagnosis of respiratory diseases. Respiratory secretions, blood, urine, mucus, and other body fluids are collected as samples for laboratory testing. Skilled technicians and physicians play a crucial role in the diagnostic process, ensuring accurate identification of pathogens.
Additionally, the global market is witnessing an increase in mergers and acquisitions (M&A) between organizations for the development and commercialization of new diagnostic instruments and tests. This trend is particularly evident in rapidly growing markets such as India, Brazil, China, and South Africa. By expanding their product offerings and improving market positioning through M and A, market vendors aim to maintain their leading positions in the market. The geriatric population is also a significant market for infectious disease diagnostics, as they are more susceptible to infections and associated deaths in American hospitals. Overall, the market for infectious disease diagnostics is expected to continue growing, driven by the need for accurate and timely diagnosis to prevent the spread of infectious diseases and save lives. Thus, such trends will shape the growth of the market during the forecast period.
The availability of counterfeit drugs in developing economies is the major challenge that affects the growth of the market. Infectious diseases pose a significant threat to personal health and public health systems, necessitating prompt diagnosis and infection control measures. Hospitals, particularly in developing countries with poor water sanitation and inadequate hygiene facilities, are hotspots for the spread of pathogens, including bacteria, viruses, fungi, parasites, and RNA viruses such as Hepatitis C. Healthcare professionals rely on various diagnostic tools and techniques, including chest X rays, CT scans, physical exams, laboratory tests, and PCR testing, to identify the causative organism in respiratory disease applications. However, the availability of counterfeit drugs in the market is a growing concern in the infectious disease diagnostics industry. These counterfeit products, which include diagnostic instruments and reagents, are a significant challenge for both private and government organizations. They not only result in financial losses for manufacturers due to decreased sales and brand reputation damage but also pose a risk to patient safety.
In addition, counterfeit drugs are prevalent in low-income and developing countries where regulations and manufacturing controls are insufficient. These drugs, which may contain impure or ineffective ingredients, provide a false sense of security to patients while potentially exacerbating their health conditions. Infections caused by these pathogens result in numerous deaths, particularly among the geriatric population, who are more susceptible to pneumococcal pneumonia and other respiratory diseases. Effective diagnostic tools and skilled technicians are essential to accurately identify the causative organism and initiate appropriate treatment. Blood, urine, mucus, and other body fluids are common samples used in laboratory tests to diagnose infectious diseases. It is crucial to prioritize infection control measures and invest in advanced diagnostic technologies to ensure accurate and timely diagnosis and improve patient outcomes. Hence, the above factors will impede the growth of the market during the forecast period
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Abbott Laboratories - The company offers infectious disease diagnostics for diseases such as SARS CoV 2, and HIV 1.
The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The hospitals segments are estimated to witness significant growth during the forecast period. The global market is driven by the urgent need for prompt diagnosis of various infectious diseases, including RNA viruses like Hepatitis C, bacteria, viruses, fungi, parasites, and other pathogens. Infection control is a critical concern in personal health, particularly in hospitals, where poor water sanitation and inadequate hygiene facilities increase the risk of infections. Healthcare professionals rely on various diagnostic methods such as chest X-rays, CT scans, physical exams, laboratory tests, PCR testing, and analysis of respiratory secretions, blood, urine, mucus, and other body fluids.
Get a glance at the market share of various regions Download the PDF Sample
The hospitals segment was the largest and was valued at USD 23.83 billion in 2018. Skilled technicians and physicians play a crucial role in identifying the causative organism from the sample. The hospital segment is expected to dominate the market due to the increasing number of patients with infectious diseases, such as pneumococcal pneumonia, which is particularly prevalent among the geriatric population. With over 50,000 hospitals worldwide, the demand for infectious disease diagnostic instruments is significant. Large-, medium-, and small-sized hospitals procure these instruments in bulk from suppliers and group purchasing organizations (GPOs), contributing to market growth. Private and government organizations also invest in advanced diagnostic technologies to improve infection control and reduce deaths caused by infectious diseases.
For more insights on the market share of various regions Download PDF Sample now!
Asia is estimated to contribute 43% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The market encompasses various medical testing solutions for the detection of tuberculosis, HIV or AIDS, hepatitis, sexually transmitted infections (STIs), respiratory infections, and other infectious diseases. Disease prevalence fuels the demand for reliable and rapid diagnostic tools in clinical laboratories, medical tourism centers, and hospital settings. Technicians in these facilities procure, store, and transport samples for pathogen detection using advanced technologies like Next Generation Sequencing. Laboratory spaces require stringent measures to prevent cross contamination, necessitating the use of specialized kits, consumables, software, and services. HIV, Chlamydia trachomatis, Neisseria gonorrhea, HPV, Influenza, Syphilis, and mosquito-borne diseases are among the common infectious diseases diagnosed in urgent care centers, emergency rooms, and ambulances. Sensitivity and specificity are crucial factors in ensuring accurate results, minimizing false negatives and positives, and providing rapid results for timely treatment.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD Billion " for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
You may also interested in below market reports:
The market is a significant and ever-evolving sector in the healthcare industry. This market plays a crucial role in identifying and diagnosing various infectious diseases, including tuberculosis, HIV or AIDS, hepatitis, sexually transmitted infections (STIs), respiratory infections, and hospital-acquired infections. Medical testing for these diseases is essential for disease prevalence monitoring, early detection, and effective treatment. Clinical laboratories, Urgent care centres, Emergency rooms, and Ambulances are the primary settings for infectious disease diagnostics. The market is driven by the increasing disease prevalence, the need for rapid results, and the growing demand for Point-of-Care (PoC) testing. Technicians in this field are responsible for procuring, storing, and transporting samples to ensure accurate pathogen detection.
In addition, the next-Generation Sequencing (NGS) technology is revolutionizing the diagnostics market by enabling the identification of multiple pathogens in a single test. However, challenges such as cross contamination and false negative or positive results remain. The market for infectious disease diagnostics includes kits, consumables, software and services, and laboratory spaces. HIV, Chlamydia trachomatis, Neisseria gonorrhea, HPV, Influenza, Syphilis, Mosquito borne diseases, and other infectious diseases are the major focus areas. In conclusion, the market is a vital sector that requires continuous innovation and improvement to address the challenges and meet the growing demand for accurate and rapid diagnostic solutions.
Market Scope |
|
Report Coverage |
Details |
Page number |
140 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 4.5% |
Market Growth 2024-2028 |
USD 8.90 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
4.23 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
Asia at 43% |
Key countries |
US, Germany, China, UK, and Canada |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., DiaSorin Spa, F. Hoffmann La Roche Ltd., Genetic Signatures Ltd., Grifols SA, Hologic Inc., Meridian Bioscience Inc., Meril Life Sciences Pvt. Ltd., OraSure Technologies Inc., Perkin Elmer Inc., QIAGEN NV, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., Trinity Biotech Plc, and Vela Diagnostics |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the market forecast period |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.